These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Safety of long-term intranasal budesonide delivered via the mucosal atomization device for chronic rhinosinusitis. Manji J; Singh G; Okpaleke C; Dadgostar A; Al-Asousi F; Amanian A; Macias-Valle L; Finkelstein A; Tacey M; Thamboo A; Javer A Int Forum Allergy Rhinol; 2017 May; 7(5):488-493. PubMed ID: 28151588 [TBL] [Abstract][Full Text] [Related]
3. The safety and efficacy of short-term budesonide delivered via mucosal atomization device for chronic rhinosinusitis without nasal polyposis. Thamboo A; Manji J; Szeitz A; Santos RD; Hathorn I; Gan EC; Alsaleh S; Javer AR Int Forum Allergy Rhinol; 2014 May; 4(5):397-402. PubMed ID: 24449682 [TBL] [Abstract][Full Text] [Related]
4. Effects of systemic steroid treatment in chronic polypoid rhinosinusitis evaluated with magnetic resonance imaging. Damm M; Jungehülsing M; Eckel HE; Schmidt M; Theissen P Otolaryngol Head Neck Surg; 1999 Apr; 120(4):517-23. PubMed ID: 10187944 [TBL] [Abstract][Full Text] [Related]
5. Comparison of intranasal fluticasone spray, budesonide atomizer, and budesonide respules in patients with chronic rhinosinusitis with polyposis after endoscopic sinus surgery. Neubauer PD; Schwam ZG; Manes RP Int Forum Allergy Rhinol; 2016 Mar; 6(3):233-7. PubMed ID: 26679480 [TBL] [Abstract][Full Text] [Related]
6. [The efficacy and safety of a short course of budesonide inhalation suspension via transnasal nebulization in chronic rhinosinusitis with nasal polyps]. Wang C; Lou H; Lou W; Zhang L Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Apr; 26(8):347-50. PubMed ID: 22730816 [TBL] [Abstract][Full Text] [Related]
7. Budesonide nasal irrigations in the postoperative management of chronic rhinosinusitis. Jang DW; Lachanas VA; Segel J; Kountakis SE Int Forum Allergy Rhinol; 2013 Sep; 3(9):708-11. PubMed ID: 23776108 [TBL] [Abstract][Full Text] [Related]
8. Effect of three-drug delivery modalities on olfactory function in chronic sinusitis. Reychler G; Colbrant C; Huart C; Le Guellec S; Vecellio L; Liistro G; Rombaux P Laryngoscope; 2015 Mar; 125(3):549-55. PubMed ID: 25224684 [TBL] [Abstract][Full Text] [Related]
9. Effect of nebulized budesonide on decreasing the recurrence of allergic fungal rhinosinusitis. Dai Q; Duan C; Liu Q; Yu H Am J Otolaryngol; 2017; 38(3):321-324. PubMed ID: 28185668 [TBL] [Abstract][Full Text] [Related]
11. [The efficacy of combining antibiotic treatment with topical intranasal steroid administration in the treatment of chronic otitis media with effusion]. Karlidağ T; Kaygusuz I; Gök U; Yalçin S; Keleş E; Oztürk L Kulak Burun Bogaz Ihtis Derg; 2002; 9(4):257-62. PubMed ID: 12422079 [TBL] [Abstract][Full Text] [Related]
12. Evaluating budesonide efficacy in nasal polyposis and predicting the resistance to treatment. Valera FC; Queiroz R; Scrideli C; Tone LG; Anselmo-Lima WT Clin Exp Allergy; 2009 Jan; 39(1):81-8. PubMed ID: 19068102 [TBL] [Abstract][Full Text] [Related]
13. The effect of topical amphotericin B on inflammatory markers in patients with chronic rhinosinusitis: a multicenter randomized controlled study. Ebbens FA; Georgalas C; Luiten S; van Drunen CM; Badia L; Scadding GK; Hellings PW; Jorissen M; Mullol J; Cardesin A; Bachert C; van Zele TP; Lund VJ; Fokkens WJ Laryngoscope; 2009 Feb; 119(2):401-8. PubMed ID: 19160404 [TBL] [Abstract][Full Text] [Related]
14. Effect of intranasal budesonide irrigations on intraocular pressure. Seiberling KA; Chang DF; Nyirady J; Park F; Church CA Int Forum Allergy Rhinol; 2013 Sep; 3(9):704-7. PubMed ID: 23704078 [TBL] [Abstract][Full Text] [Related]
15. Trial of prophylactic inhaled steroids to prevent or reduce pulmonary function decline, pulmonary symptoms, and airway hyperreactivity in firefighters at the world trade center site. Banauch GI; Izbicki G; Christodoulou V; Weiden MD; Webber MP; Cohen H; Gustave J; Chavko R; Aldrich TK; Kelly KJ; Prezant DJ Disaster Med Public Health Prep; 2008 Mar; 2(1):33-9. PubMed ID: 18388656 [TBL] [Abstract][Full Text] [Related]
16. Topical tacrolimus 0.1% improves symptoms of hand dermatitis in patients treated with a prednisone taper. Krejci-Manwaring J; McCarty MA; Camacho F; Manuel J; Hartle J; Fleischer A; Feldman SR J Drugs Dermatol; 2008 Jul; 7(7):643-6. PubMed ID: 18664156 [TBL] [Abstract][Full Text] [Related]
17. Regulation of glucocorticoid receptor in nasal polyps by systemic and intranasal glucocorticoids. Pujols L; Alobid I; Benítez P; Martínez-Antón A; Roca-Ferrer J; Fokkens WJ; Mullol J; Picado C Allergy; 2008 Oct; 63(10):1377-86. PubMed ID: 18671773 [TBL] [Abstract][Full Text] [Related]
18. Rhinologic outcomes of concurrent operation for pituitary adenoma and chronic rhinosinusitis: an early experience. Heo KW; Park SK Am J Rhinol; 2008; 22(5):533-6. PubMed ID: 18954516 [TBL] [Abstract][Full Text] [Related]
19. Budesonide in the treatment of refractory celiac disease. Brar P; Lee S; Lewis S; Egbuna I; Bhagat G; Green PH Am J Gastroenterol; 2007 Oct; 102(10):2265-9. PubMed ID: 17581265 [TBL] [Abstract][Full Text] [Related]
20. Multimodality topical therapy for refractory chronic rhinosinusitis: our experience in thirteen patients with and twelve patients without nasal polyps. Shikani AH; Kourelis K; Alqudah MA; Shikani HJ; Cope E; Kirk N; Bergstedt D; Basaraba RJ; Leid JG Clin Otolaryngol; 2013 Jun; 38(3):254-8. PubMed ID: 23398898 [No Abstract] [Full Text] [Related] [Next] [New Search]